NCT05711797View on ClinicalTrials.gov

Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

April 12, 2023

Primary Completion Date

February 6, 2024

Study Completion Date

August 9, 2024

Conditions
Influenza, Human
Interventions
DRUG

ZX-7101A 80mg

ZX-7101A a drug to treatment influenza in Chinese adults

Trial Locations (1)

Unknown

Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai

Sponsors
All Listed Sponsors
lead

Nanjing Zenshine Pharmaceuticals

INDUSTRY

NCT05711797 - Pharmacokinetic Characteristics of Subjects with Hepatic Insufficiency and Healthy Subjects | Biotech Hunter | Biotech Hunter